Clinical Trials · NCT03737240

IDegLira HIGH Trial

CompletedPhase 3Liraglutide (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
Emory University
Enrollment
145
Start date
Jan 2019
Locations
2 sites, United States
Primary endpoint
Change in Hemoglobin A1c (HbA1c)
View Liraglutide compound reference